Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B. Cohen, Julio A. Chirinos, Juan E. Rodriguez‐Mori et al.|The Lancet Respiratory Medicine|2021Cited by 224
Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19Charles R. Vasquez, Steven G. Coca, Shruti Gupta et al.|CHEST Journal|2021Cited by 40
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial ProtocolJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|Journal of Clinical Hypertension|2020Cited by 19